The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors

Alon D. Altman, Gregg S. Nelson, Prafull Ghatage, John B. McIntyre, David Capper, Pamela Chu, Jill G. Nation, Anthony Karnezis, Guangming Han, Steve E. Kalloger, Martin Köbel

Research output: Contribution to journalArticle

31 Scopus citations

Fingerprint Dive into the research topics of 'The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences